Copyright
©The Author(s) 2023.
World J Cardiol. Jun 26, 2023; 15(6): 309-323
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.309
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.309
Figure 2 No evidence of publication bias.
A: When studies have been divided based on the incidence of fibrinolysis; B: When studies have been divided based on the income status of countries. HIC: High-income countries; LMIC: Low- and middle-income countries.
- Citation: Khedr A, Hennawi HA, Khan MK, Elbanna M, Jama AB, Proskuriakova E, Mushtaq H, Mir M, Boike S, Rauf I, Eissa A, Urtecho M, Koritala T, Jain N, Goyal L, Surani S, Khan SA. Effect of fibrinolytic therapy on ST-elevation myocardial infarction clinical outcomes during the COVID-19 pandemic: A systematic review and meta-analysis. World J Cardiol 2023; 15(6): 309-323
- URL: https://www.wjgnet.com/1949-8462/full/v15/i6/309.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i6.309